Report
Chris Kallos

Stable, high-quality Australian diagnostic earnings fund increasingly meaningful offshore growth.

Following a solid performance in the six months to December, narrow-moat Sonic Healthcare is on track to meet our fiscal 2018 forecasts for EBITDA of AUD 953 million. This compares with full-year guidance reiterated by management of between AUD 942 million and AUD 960 million. As such, we are leaving our fair value estimate unchanged at AUD 24 per share. At current levels, we think shares in Sonic are fairly valued. The company delivered adjusted net profit after tax, or NPAT, of AUD 209 million...
Underlying
Sonic Healthcare Limited

Sonic Healthcare is involved in the provision of medical diagnostic services and the provision of administrative services and facilities to medical practitioners. Co. provides specialized pathology/clinical laboratory and diagnostic imaging services to clinicians, hospitals, community health services, and their patients. Co.'s segments are comprised of: Laboratory, which provides Pathology/clinical laboratory services in Australia, New Zealand, the U.K., the U.S., Germany, Switzerland, Belgium and Ireland; Imaging, which provides diagnostic imaging services in Australia; and Other, which Includes medical center operations and occupational health services.

Provider
Morningstar
Morningstar

Morningstar, Inc. is a leading provider of independent investment research in North America, Europe, Australia, and Asia. The company offer an extensive line of products and services for individual investors, financial advisors, asset managers, and retirement plan providers and sponsors.

Morningstar provides data on approximately 530,000 investment offerings, including stocks, mutual funds, and similar vehicles, along with real-time global market data on more than 18 million equities, indexes, futures, options, commodities, and precious metals, in addition to foreign exchange and Treasury markets. Morningstar also offers investment management services through its investment advisory subsidiaries and had approximately $185 billion in assets under advisement and management as of June 30, 2016.

We have operations in 27 countries.

Analysts
Chris Kallos

Other Reports on these Companies
Other Reports from Morningstar

ResearchPool Subscriptions

Get the most out of your insights

Get in touch